| Reporting Segment | Product Linearrow_drop_up | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Captisol |
Active Pharma Ingredients (outsourced)
These companies develop Active Pharmaceutical Ingredients (APIs) that are used to create finished drugs, and use contract manufacturers to actually produce the APIs.
|
28.37M | 21.61% |
| Contract Revenue |
Pharmaceutical Contract Developer and Manufacturing Organizations (CDMOs)
These companies, commonly known as CDMOs, provide specialized services for drug manufacturers, such as drug discovery, research, development, and manufacturing.
|
19.03M | 14.49% |
| Royalties |
Pharmaceutical Patent Licensing
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
83.91M | 63.90% |
| Captisol |
Pre-Revenue Pharmaceuticals
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
Non-Attributed |
Non-Attributed
help
Why Zero? Explanation of what the heck's going on here.
|
| keyboard_arrow_down |
Captisol
Active Pharma Ingredients (outsourced)
|
28.37M | 21.61% |
| keyboard_arrow_right |
These companies develop Active Pharmaceutical Ingredients (APIs) that are used to create finished drugs, and use contract manufacturers to actually produce the APIs.
|
||
| keyboard_arrow_down |
Contract Revenue
Pharmaceutical Contract Developer and Manufacturing Organizations (CDMOs)
|
19.03M | 14.49% |
| keyboard_arrow_right |
These companies, commonly known as CDMOs, provide specialized services for drug manufacturers, such as drug discovery, research, development, and manufacturing.
|
||
| keyboard_arrow_down |
Royalties
Pharmaceutical Patent Licensing
|
83.91M | 63.90% |
| keyboard_arrow_right |
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
||
| keyboard_arrow_down |
Captisol
Pre-Revenue Pharmaceuticals
|
Non-Attributed |
Non-Attributed
help
Why Zero? Explanation of what the heck's going on here.
|
| keyboard_arrow_right |
help
Why Zero? Explanation of what the heck's going on here.
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
||